[
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From Amgen’s Q1 Earnings Call",
    "summary": "Amgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both general medicine and specialty disease areas. Management highlighted strong double-digit growth from 14 medicines, including continued momentum in cardiovascular, bone health, and biosimilars. CEO Robert Bradway attributed the performance to “growing patient demand for our innovative medicines” and called out the breadth of the company’s pipeline progress, including multi",
    "url": "https://finnhub.io/api/news?id=ccc1c06cb965021f49bf70ac82906d7361f8ae85dc9b4a119e3d29583d09b0bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750924940,
      "headline": "5 Insightful Analyst Questions From Amgen’s Q1 Earnings Call",
      "id": 135558782,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both general medicine and specialty disease areas. Management highlighted strong double-digit growth from 14 medicines, including continued momentum in cardiovascular, bone health, and biosimilars. CEO Robert Bradway attributed the performance to “growing patient demand for our innovative medicines” and called out the breadth of the company’s pipeline progress, including multi",
      "url": "https://finnhub.io/api/news?id=ccc1c06cb965021f49bf70ac82906d7361f8ae85dc9b4a119e3d29583d09b0bb"
    }
  },
  {
    "ts": null,
    "headline": "AMG River Road Dividend All Cap Value Fund Q1 2025 Commentary",
    "summary": "AMG River Road Dividend All Cap Value Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=f63f006097592800d31e02591fabbbbe6a4c6228d0dcca88c899ab0a4d42cae6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750918200,
      "headline": "AMG River Road Dividend All Cap Value Fund Q1 2025 Commentary",
      "id": 135550745,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f63f006097592800d31e02591fabbbbe6a4c6228d0dcca88c899ab0a4d42cae6"
    }
  },
  {
    "ts": null,
    "headline": "AMG Montrusco Bolton Large Cap Growth Fund Q1 2025 Commentary",
    "summary": "AMG Montrusco Bolton Large Cap Growth Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=1c474c655ef68acd9258781d828a7d18578ea24ef5df7ceda1fb3eb71bdb923a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750916700,
      "headline": "AMG Montrusco Bolton Large Cap Growth Fund Q1 2025 Commentary",
      "id": 135546973,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=1c474c655ef68acd9258781d828a7d18578ea24ef5df7ceda1fb3eb71bdb923a"
    }
  }
]